Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Company-reported Phase 3 topline results have circulated in 20252026, and a regulatory filing has been anticipated, but retatrutide is not FDA- or EMA-approved and is not available as a prescription product
, ,
Previous medications in this space include Semaglutide (marketed as Wegovy and Ozempic) and Tirzepatide (marketed as Mounjaro and Zepbound)
Ali points out that the retatrutide clinical trials are lasting longer than previous trials for already approved GLP-1 drugs
US$ 21.71
US$ 29.63
US$ 22.32
US$ 27.08
US$ 28.37
US$ 29.75
